Literature DB >> 29225341

Humoral immunity, the underestimated player in hepatitis B.

Shuye Zhang1, Juanjuan Zhao2, Zheng Zhang3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29225341      PMCID： PMC6078975          DOI： 10.1038/cmi.2017.132

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN： 1672-7681            Impact factor:   11.530


× No keyword cloud information.
  20 in total

1.  Control of hepatitis B virus infection in hematopoietic stem cell recipients after receiving grafts from vaccinated donors.

Authors:  M Lindemann; M Koldehoff; M Fiedler; A Schumann; H D Ottinger; F M Heinemann; M Roggendorf; P A Horn; D W Beelen
Journal:  Bone Marrow Transplant       Date:  2015-10-26       Impact factor: 5.483

2.  Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigen.

Authors:  Tian-Ying Zhang; Quan Yuan; Jing-Hua Zhao; Ya-Li Zhang; Lun-Zhi Yuan; Ying Lan; Yu-Chieh Lo; Cheng-Pu Sun; Chang-Ru Wu; Jun-Fang Zhang; Ying Zhang; Jia-Li Cao; Xue-Ran Guo; Xuan Liu; Xiao-Bing Mo; Wen-Xin Luo; Tong Cheng; Yi-Xin Chen; Mi-Hua Tao; James Wk Shih; Qin-Jian Zhao; Jun Zhang; Pei-Jer Chen; Y Adam Yuan; Ning-Shao Xia
Journal:  Gut       Date:  2015-09-30       Impact factor: 23.059

3.  Antibody-mediated immunotherapy against chronic hepatitis B virus infection.

Authors:  Ying Gao; Tian-Ying Zhang; Quan Yuan; Ning-Shao Xia
Journal:  Hum Vaccin Immunother       Date:  2017-05-19       Impact factor: 3.452

4.  Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection.

Authors:  Ji-Ming Zhang; Yang Xu; Xin-Yu Wang; You-Kuan Yin; Xiang-Hui Wu; Xin-Hua Weng; Mengji Lu
Journal:  Clin Infect Dis       Date:  2007-03-19       Impact factor: 9.079

Review 5.  Exploring Human Antimicrobial Antibody Responses on a Single B Cell Level.

Authors:  Daniel Hofmann; Jonathan R Lai
Journal:  Clin Vaccine Immunol       Date:  2017-05-05

6.  Re-evaluation of hepatitis B virus clinical phases by systems biology identifies unappreciated roles for the innate immune response and B cells.

Authors:  Thomas Vanwolleghem; Jun Hou; Gertine van Oord; Arno C Andeweg; A D M E Osterhaus; Suzan D Pas; Harry L A Janssen; Andre Boonstra
Journal:  Hepatology       Date:  2015-04-27       Impact factor: 17.425

7.  Hepatitis B virus infection.

Authors:  Yun-Fan Liaw; Chia-Ming Chu
Journal:  Lancet       Date:  2009-02-14       Impact factor: 79.321

8.  Adoptive immune transfer of hepatitis B virus specific immunity from immunized living liver donors to liver recipients.

Authors:  Alexandra Schumann; Monika Lindemann; Camino Valentin-Gamazo; Mengji Lu; Ahmet Elmaagacli; Uta Dahmen; Dietmar Knop; Christoph E Broelsch; Hans Grosse-Wilde; Michael Roggendorf; Melanie Fiedler
Journal:  Transplantation       Date:  2009-01-15       Impact factor: 4.939

9.  IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection.

Authors:  Abhishek Das; Gidon Ellis; Celeste Pallant; A Ross Lopes; Pooja Khanna; Dimitra Peppa; Antony Chen; Paul Blair; Geoffrey Dusheiko; Upkar Gill; Patrick T Kennedy; Maurizia Brunetto; Pietro Lampertico; Claudia Mauri; Mala K Maini
Journal:  J Immunol       Date:  2012-09-12       Impact factor: 5.422

10.  A novel therapeutic anti-HBV antibody with increased binding to human FcRn improves in vivo PK in mice and monkeys.

Authors:  Ciming Kang; Lin Xia; Yuanzhi Chen; Tianying Zhang; Yiwen Wang; Bing Zhou; Min You; Quan Yuan; Chi-Meng Tzeng; Zhiqiang An; Wenxin Luo; Ningshao Xia
Journal:  Protein Cell       Date:  2018-01       Impact factor: 14.870
View more
  5 in total

1.  B10 Cells Are Associated With Clinical Prognosis During Adult Symptomatic Acute HBV Infection.

Authors:  Yali Liu; Xiaofei Du; Junfeng Lu; Lina Ma; Yi Jing; Haijing Ben; Xinyue Chen; Jing Zhang
Journal:  Front Immunol       Date:  2022-06-13       Impact factor: 8.786

2.  Hepatitis B virus reactivation in a myeloma patient with resolved infection who received daratumumab-containing salvage chemotherapy.

Authors:  Takaki Kikuchi; Shigeru Kusumoto; Yasuhito Tanaka; Yoshiko Oshima; Haruna Fujinami; Tomotaka Suzuki; Haruhito Totani; Shiori Kinoshita; Yu Asao; Tomoko Narita; Asahi Ito; Masaki Ri; Hirokazu Komatsu; Shinsuke Iida
Journal:  J Clin Exp Hematop       Date:  2020-05-13

3.  CD4+ T Cells Play a Critical Role in Microbiota-Maintained Anti-HBV Immunity in a Mouse Model.

Authors:  Tingxin Wu; Fenglei Li; Yongyan Chen; Haiming Wei; Zhigang Tian; Cheng Sun; Rui Sun
Journal:  Front Immunol       Date:  2019-04-30       Impact factor: 7.561

4.  Anti-HBc IgG Responses Occurring at the Early Phase of Infection Correlate Negatively with HBV Replication in a Mouse Model.

Authors:  Xuyang Wang; Yumeng Zhang; Yinyin Ben; Chao Qiu; Jing Wu; Wenhong Zhang; Yanmin Wan
Journal:  Viruses       Date:  2022-09-11       Impact factor: 5.818

Review 5.  HBV-Induced Immune Imbalance in the Development of HCC.

Authors:  Yongyan Chen; Zhigang Tian
Journal:  Front Immunol       Date:  2019-08-27       Impact factor: 7.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.